FDA Approved: CLADRIBINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cladribine from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia
• Multiple Sclerosis

Drugs mentioned

• Cladribine (cladribine)

Snippet

SUPPL AP for CLADRIBINE (CLADRIBINE)